Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

JMP Securities Maintains Market Outperform on Gritstone Bio, Raises Price Target to $5

Author: Benzinga Newsdesk | April 02, 2024 02:09pm
JMP Securities analyst Roy Buchanan maintains Gritstone Bio (NASDAQ:GRTS) with a Market Outperform and raises the price target from $4 to $5.

Posted In: GRTS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist